Linda Green
Physician Assistant · Minerva, OHNPI 1619979721
Payments from drug & device makers
Across 133 payments — averaging $14.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$412
- Pfizer$262
- Lilly USA, LLC$255
- Takeda Pharmaceuticals U.S.A., Inc.$189
- GSK$152
- Johnson & Johnson$93
- plus $579 from 17 others
What the payments were for
- Food & beverage$1,943100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $412 |
| Pfizer | 17 | $262 |
| Lilly USA, LLC | 19 | $255 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $189 |
| GSK | 10 | $152 |
| Johnson & Johnson | 7 | $93 |
| Merck | 6 | $85 |
| AstraZeneca | 5 | $65 |
| Sanofi-aventis U.S. LLC | 4 | $57 |
| Boehringer Ingelheim | 4 | $51 |
| Teva Pharmaceuticals USA, Inc. | 3 | $42 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Exact Sciences | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Astellas Pharma US Inc | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $28 |
| Biohaven Pharmaceuticals, Inc. | 2 | $27 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| VBI Vaccine (delaware) Inc. | 1 | $19 |
| Novo Nordisk | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
How this compares
$1,943 in reported general payments places this provider in the 85th percentile of 4,098 physician assistant providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 20 | $18,580 |
| Rosuvastatin Calcium | 22 | $412 |
| Atorvastatin Calcium | 84 | $375 |
| Lisinopril | 52 | $351 |
| Metoprolol Succinate | 21 | $294 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $288 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 28 | $285 |
| Amlodipine Besylate | 51 | $250 |
| Omeprazole | 19 | $234 |
| Pantoprazole Sodium | 16 | $181 |
| Levothyroxine Sodium | 13 | $142 |
| Glipizide ErGlipizide | 12 | $138 |
| Fluticasone Propionate | 13 | $116 |
| Metformin Hcl ErMetformin Hcl | 19 | $104 |
| Finasteride | 14 | $96 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $51 | $18,58020 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,098 physician assistant providers in Ohio.
Other physician assistant in Minerva
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Natalie WalkupSylvania$105K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
- Alan OdonnellCincinnati$71K
- Brook GramBeloit$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.